INDSWFTLABNSEInd-Swift Laboratories Limited· PharmaceuticalsMediumNeutral
Announced Mon, 30 Mar · 19:12 IST

Ind-Swift Laboratories Limited has informed the Exchange regarding Notice of Postal Ballot

Board & Shareholder Meetings View source PDF

INDSWFTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+5.8%1-day move
₹130.50
prior close
₹135.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.9+3.7+3.5+3.5+5.8+7.5+5.7+17.9+9.9+6.2+4.4+5.1+26.4+54.3
Up moveDown movePending
AI summary

Ind-Swift Laboratories has issued a Postal Ballot notice seeking shareholder approval through e-voting for four special resolutions. Resolution 1 seeks approval to change N.R. Munjal's designation from Chairman & Managing Director to Chairman & Whole-Time Director, with a salary range of Rs. 30 lakh to Rs. 60 lakh per month. Resolution 2 appoints Himanshu Jain as Managing Director (Domestic Operations) with a salary range of Rs. 24 lakh to Rs. 50 lakh per month. Resolution 3 appoints Sahil Munjal as Managing Director (Global Operations) with the same salary range. Resolution 4 approves remuneration for Whole-Time Director Rishav Mehta for a two-year period from March 23, 2026 to March 22, 2028, also in the Rs. 24 lakh to Rs. 50 lakh per month range. All four directors are also eligible for commission up to 1% of net profits, perquisites, and pension benefits. The e-voting window runs from April 1, 2026 to April 30, 2026, and results will be announced within two working days after that.

Likely market impact

These resolutions formalise the company's leadership structure by splitting domestic and global operations under separate Managing Directors while keeping the Munjal family in key executive roles. Shareholders should review the remuneration levels, which may exceed standard statutory limits, and vote during the e-voting period if they wish to influence the outcomes.